To perform a direct comparison between the repertoires and coverage of HLA-I and HLA-II in the context of these antigens and IFNγ treatment, we examined the 115 shared (Figure 3C) cancer associated antigens present in the HLA-I and HLA-II peptide datasets. Here, IFNG is linked to cancer.